BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysacc…
Biotechnology
US, San Rafael [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | 87.00 | 18.00 | 18.00 | 17.00 | -59.00 | -73.00 | -221.00 | -227.00 | -8.00 | 20.00 | 48.00 | 85.00 | 304.00 | 175.00 | 159.00 | |
| Operating Cash (Net) | 87.00 | 18.00 | 18.00 | 17.00 | -59.00 | -73.00 | -221.00 | -227.00 | -8.00 | 20.00 | 48.00 | 85.00 | 304.00 | 175.00 | 159.00 | |
| Accounts Receivable | -19.00 | -13.00 | -18.00 | -4.00 | -8.00 | -26.00 | -16.00 | -51.00 | -25.00 | -54.00 | -37.00 | -59.00 | 65.00 | -82.00 | -190.00 | |
| Accounts Payable | 8.00 | 5.00 | 12.00 | 33.00 | 8.00 | 36.00 | 116.00 | -33.00 | 24.00 | 20.00 | 50.00 | -68.00 | 15,689.00 | 59.00 | 68.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | 19.00 | -42.00 | -25.00 | 33.00 | -23.00 | -30.00 | 46.00 | -160.00 | -93.00 | -49.00 | -101.00 | -224.00 | 66.00 | -96.00 | -336.00 | |
| Other WC | 36.00 | -3.00 | 1.00 | 1.00 | 11.00 | -3.00 | -2.00 | -10.00 | 3.00 | 7.00 | -5.00 | -35.00 | -15,653.00 | -5.00 | -57.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | -79.00 | -101.00 | -89.00 | -195.00 | -298.00 | 194.00 | -1,179.00 | -484.00 | -305.00 | 264.00 | -31.00 | -53.00 | -366.00 | -20.00 | -111.00 | |
| Capital Expenditure | -89.00 | -49.00 | -154.00 | -44.00 | -65.00 | -118.00 | -227.00 | -148.00 | -199.00 | -144.00 | -163.00 | -137.00 | -119.00 | -131.00 | -107.00 | |
| Purchases of Investments | -439.00 | -225.00 | -217.00 | -387.00 | -395.00 | -559.00 | -876.00 | -699.00 | -655.00 | -634.00 | -632.00 | -538.00 | -937.00 | -611.00 | -868.00 | |
| Sale/Maturity of Investment | 475.00 | 206.00 | 281.00 | 237.00 | 288.00 | 808.00 | 424.00 | 367.00 | 425.00 | 993.00 | 740.00 | 555.00 | 691.00 | 619.00 | 864.00 | |
| Property, Plant, Equipment (P&PE) | -89.00 | -49.00 | -154.00 | -44.00 | -65.00 | -118.00 | -227.00 | -148.00 | -199.00 | -144.00 | -163.00 | -137.00 | -119.00 | -131.00 | -107.00 | |
| Acquisitions (Net) | -8.00 | -32.00 | 81.00 | -1.00 | -10.00 | -1.00 | -910.00 | -2.00 | 125.00 | 50.00 | 6.00 | -23.00 | -23.00 | - - | 10,920.00 | |
| Other Investing Activities | -17.00 | - - | -81.00 | -151.00 | -116.00 | 65.00 | 410.00 | - - | -1.00 | - - | 17.00 | 89.00 | 22.00 | 103.00 | -10,920.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -63.00 | -3.00 | -29.00 | -312.00 | -746.00 | -185.00 | -927.00 | -727.00 | -507.00 | -388.00 | -74.00 | -181.00 | - - | -18.00 | -18.00 | |
| Debt Repayment | -73.00 | -30.00 | -5.00 | - - | -13.00 | - - | - - | - - | -481.00 | -374.00 | -5.00 | -381.00 | -3.00 | -2.00 | -2.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | 237 | 6 | 125 | 911 | 772 | 94 | 103 | 74 | 121 | 94 | 123 | 145 | |
| Issued | - - | - - | - - | 235.00 | - - | 117.00 | 888.00 | 712.00 | 60.00 | 67.00 | 31.00 | 71.00 | 49.00 | 69.00 | 69.00 | |
| Repurchased | - - | - - | - - | -1.00 | -6.00 | -7.00 | -22.00 | -59.00 | -33.00 | -35.00 | -42.00 | -50.00 | -45.00 | -54.00 | -76.00 | |
| Other Financing Activities | 9.00 | 33.00 | 34.00 | 77.00 | 760.00 | 68.00 | 39.00 | 14.00 | 507.00 | -13.00 | -47.00 | 613.00 | 2.00 | -16.00 | -85.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 222.00 | 167.00 | 88.00 | 46.00 | 180.00 | 568.00 | 875.00 | 397.00 | 408.00 | 598.00 | 493.00 | 437.00 | 649.00 | 587.00 | 724.00 | |
| End of Period | 167.00 | 88.00 | 46.00 | 180.00 | 568.00 | 875.00 | 397.00 | 408.00 | 598.00 | 493.00 | 437.00 | 649.00 | 587.00 | 724.00 | 755.00 | |
| Change | -55.00 | -79.00 | -41.00 | 134.00 | 388.00 | 306.00 | -478.00 | 11.00 | 189.00 | -104.00 | -56.00 | 211.00 | -61.00 | 137.00 | 30.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 20.00 | 27.00 | 36.00 | 45.00 | 47.00 | 56.00 | 47.00 | 96.00 | 87.00 | 95.00 | 105.00 | 105.00 | 108.00 | 101.00 | 104.00 | |
| Stock Based Compensation | 36.00 | 38.00 | 43.00 | 47.00 | 66.00 | 88.00 | 111.00 | 134.00 | 140.00 | - - | 159.00 | 189.00 | 197.00 | 196.00 | 207.00 | |
| Other | 2.00 | 19.00 | 13.00 | 16.00 | 35.00 | -28.00 | -178.00 | 559.00 | -70.00 | -29.00 | -9.00 | 44.00 | 12.00 | -115.00 | 756.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -2.00 | -30.00 | -135.00 | -26.00 | -124.00 | -192.00 | -449.00 | -376.00 | -207.00 | -124.00 | -115.00 | -52.00 | 185.00 | 44.00 | 51.00 | |
| Cash Conversion Cycle (CCC) | 518.00 | 627.00 | 598.00 | 6.00 | 334.00 | -31.00 | -222.00 | 43.00 | 184.00 | 192.00 | 192.00 | 441.00 | 526.00 | 580.00 | 596.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | -2.00 | -3.00 | -5.00 | -3.00 | -3.00 | - - | - - | -1.00 | - - | - - | 1,308.00 |